EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Treatment Landscape of Metabolic-Dysfunction-Associated Steatotic Liver Disease

Pranav Patel iD

Journal of Clinical Medicine · 27.08.2025 · 14 (17) · 6060

DOI: 10.3390/jcm14176060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.08.2025. Verfasst von Pranav Patel. Beteiligte Einrichtung: Prisma Health Greenville Memorial Hospital, Greenville, SC 29605, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The incidence of metabolic-dysfunction-associated steatotic liver disease (MASLD) is on the rise worldwide. The purpose of this paper is to review the current and emerging trends in the management and treatment of this condition.

Methods

A comprehensive literature review was conducted using PubMed and GoogleScholar, focusing on articles published within the last ten years.

Results

As the incidence of MASLD rises worldwide, it is becoming ever more important to call attention to disease prevention and progression. Although weight loss, diet, and exercise play a major role, certain therapies including GLP-1 receptor agonists, resmetirom, lanifibranor, and FGF-3 analogs are showing promise when treating patients with MASLD. As more drugs become available, it will be important to note how these medications change the global outlook of this disease.

Conclusions

Overall, the treatment landscape of MASLD is rapidly changing. Several phase 3 trials have revealed promising data when it comes to improving liver fibrosis and histology. This shift in treatment will provide new hope for patients and clinicians when treating this challenging disease.

Schlagwörter

Stichwörter der Autor:innen

FGF-analogsGLP-1MASLDSGLT-2sfatty liver diseaselanifibranornovel therapeuticsnovel therapeutics in MASLDresmetiromtreatment of MASLD

Autor:innen und Institutionen

  • Prisma Health Greenville Memorial Hospital, Greenville, SC 29605, USA.

ORCID-Profile: Pranav Patel

Zitieren

APA

Patel, P. (2025). Treatment Landscape of Metabolic-Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Medicine, 14(17), 6060. https://doi.org/10.3390/jcm14176060

Vancouver

Patel P. Treatment Landscape of Metabolic-Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Medicine. 2025;14(17):6060. doi:10.3390/jcm14176060

BibTeX
@article{Patel2025,
  author = {Patel, Pranav},
  title = {Treatment Landscape of Metabolic-Dysfunction-Associated Steatotic Liver Disease},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {17},
  pages = {6060},
  doi = {10.3390/jcm14176060}
}
Kostenlos starten →